<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0142">Therapeutic antibodies currently represent the fastest growing biotech sector, however very little is known about their body distribution following an infusion 
 <xref rid="JVEv5-bib-0054" ref-type="bibr">[54]</xref>. Dr Hope focused specifically on how function-enhancing modifications can dramatically alter their body distribution 
 <italic>in vivo</italic>. He described how the VRC01 LS mutation, a change in the Fc fragment made to prolong the antibody half-life, alters its pattern of early distribution in primates.
</p>
